Catalyst Pharmaceuticals Inc (CPRX)
Fixed asset turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 398,204 | 348,393 | 302,949 | 256,480 | 214,203 | 191,755 | 170,465 | 153,717 | 140,833 | 133,539 | 126,902 | 120,142 | 119,073 | 118,181 | 119,761 | 118,994 | 102,306 | 72,683 | 41,786 | 12,948 |
Property, plant and equipment | US$ in thousands | 1,195 | 1,186 | 1,203 | 1,285 | 847 | 882 | 917 | 925 | 959 | 951 | 914 | 944 | 130 | 149 | 168 | 197 | 210 | 141 | 148 | 140 |
Fixed asset turnover | 333.23 | 293.75 | 251.83 | 199.60 | 252.90 | 217.41 | 185.89 | 166.18 | 146.85 | 140.42 | 138.84 | 127.27 | 915.95 | 793.16 | 712.86 | 604.03 | 487.17 | 515.48 | 282.34 | 92.49 |
December 31, 2023 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $398,204K ÷ $1,195K
= 333.23
The fixed asset turnover ratio indicates how efficiently Catalyst Pharmaceuticals Inc is utilizing its fixed assets to generate sales revenue. A higher fixed asset turnover ratio suggests that the company is effectively generating revenue from its fixed assets.
Analyzing the trend of Catalyst Pharmaceuticals Inc's fixed asset turnover ratio over the past five years, there appears to be some fluctuations. The ratio has generally been increasing, with occasional fluctuations in certain quarters. For example, the ratio sharply increased from 92.49 in March 2019 to 487.17 in December 2019, indicating a significant improvement in asset utilization efficiency during that period.
In recent quarters, the fixed asset turnover ratio has been consistently high, especially peaking at 333.23 in December 2023. This suggests that Catalyst Pharmaceuticals Inc has been efficiently utilizing its fixed assets to generate sales revenue.
Overall, the trend in the fixed asset turnover ratio for Catalyst Pharmaceuticals Inc reflects a positive performance in terms of efficient utilization of fixed assets to drive revenue generation. It is essential for the company to maintain this efficiency and potentially further improve it to ensure sustainable growth and profitability in the future.
Peer comparison
Dec 31, 2023